[Home][Profile][Hours][Directions][Map][Hospitals][Groups][Insurance][Payment][Contact][resume][Carl's cv][Calendar][Services][What's New]

[Resume]

[Dividing Line Image]

curriculum vitae (for printable PDF version click here)

William F. Owen, Jr., M.D.

office address

Sutter Pacific Medical Foundation
45 Castro Street, Suite 402
San Francisco, California 94114-1040

office telephone

+1 (415) 600-4750

citizenship

U.S.

languages

English: native language, fluent

Spanish: basic reading, writing, speaking, comprehension

Portuguese (Brazilian): basic reading, writing, speaking, comprehension

education

Temple University
Philadelphia, Pennsylvania
1965-1969
Bachelor of Arts Degree cum laude, 1969

Temple University School of Medicine
Philadelphia, Pennsylvania
1969-1973
Doctor of Medicine, 1973

Baystate Medical Center
An Affiliate of Tufts University School of Medicine
Springfield, Massachusetts
Residency in Internal Medicine, 1973-1976

University of California San Francisco
San Francisco, California
Fellowship in Emergency Medicine, 1976-1978

positions held

Coordinator of Emergency Medicine Education, 1978-1979
University of California San Francisco
San Francisco, California

Private Practice, 1979-2014
Internal Medicine and HIV Medicine
San Francisco, California

Staff Physician, 2015 to present
Sutter Pacific Medical Foundation
San Francisco, California

licensure &
certification

Medical Licensure:
California G-031385

Specialty Certification: Internal Medicine
Diplomate, American Board of Internal Medicine, 1976

Subspecialty Credentials: HIV Medicine
American Academy of HIV Medicine, 2001-2015

professional
associations

American Medical Association

California Medical Association

San Francisco Medical Society

American College of Physicians

Union of American Physicians and Dentists

Infectious Diseases Society of America: HIV Medicine Association

International AIDS Society

American Academy of HIV Medicine

California Academy of HIV Medicine

Community Consortium on AIDS of San Francisco

Gay and Lesbian Medical Association
(formerly American Association of Physicians for Human Rights)

Bay Area Physicians for Human Rights

Founder: 1977

Secretary: 1977-1980

Member: 1977-present

hospital affiliations

Active Staff
California Pacific Medical Center
Castro & Duboce Streets
San Francisco, California 94114

other professional activities

Member of Board of Consulting Editors,
Journal of Homosexuality
1984 to present

Consultant to Task Force on AIDS,
California Medical Association
1982-1989

Member of AIDS Medical Advisory Committee,
Department of Public Health,
City and County of San Francisco
1986-1988

honors & awards

In 1982, the University of California, San Diego designated the first clinic in the San Diego area to serve the health needs of gay and lesbian patients as "The Owen Clinic" in honor of William F. Owen, Jr., M.D.

On October 13, 1988, at its Annual Meeting in Atlanta, Georgia, the American Society of Internal Medicine named William F. Owen, Jr., M.D. as the recipient of its 1988 Special Recognition Award, in honor of his work with patients with human immunodeficiency virus.

In June, 2000, Dr. Owen was honored with the annual Gay Pride Community Service Award by San Francisco PBS affiliate KQED.

In January 2004, San Francisco Magazine named Dr. Owen as one of the best HIV/AIDS doctors in the San Francisco Bay Area.

In January 2005, San Francisco Magazine named Dr. Owen as one of the top primary care physicians in the San Francisco Bay Area.

In its Winter/Spring 2006 issue, Bay Area Consumer Checkbook named Dr. Owen as one of the top-rated primary care physicians in the San Francisco Bay Area.

At its 35th anniversary meeting, in June 2012, Bay Area Physicians for Human Rights (BAPHR) named Dr. William Owen as "Visionary of the Decades".

Dr. Bill Owen has also been elected by his peers for inclusion in Best Doctors in America from 2003 to 2012.

publications: peer reviewed journals

Owen WF Jr.
Sexually transmitted diseases and traumatic problems in homosexual men [Review].
Ann Intern Med. 1980 Jun;
92(6):805-8.
Owen WF Jr.
The clinical approach to the homosexual patient.
Ann Intern Med. 1980 Jul;
93(1):90-2.
McGhee RD, Owen WF Jr.
Medical aspects of homosexuality [letter].
N Engl J Med. 1980 Jul 3;
303(1):50-1.
Bolan RK, Owen WF Jr, Owen RL.
Hepatitis B and sexual practices [letter].
Ann Intern Med. 1982 May;
96(5):678.
Owen WF Jr.
Sexually transmitted diseases in the homosexual community.
Dermatol Clin North Am. 1983 Jan;
1(1):123-9.
Owen WF Jr.
Medical problems of the homosexual adolescent.
J Adolesc Health Care. 1985 Jul;
6(4):278-85.
Owen WF Jr.
The clinical approach to the male homosexual patient.
Med Clin North Am. 1986 May;
70(3):499-535.
Bush RA Jr, Owen WF Jr.
Trauma and other noninfectious problems in homosexual men.
Med Clin North Am. 1986 May;
70(3):549-66.
Owen WF Jr.
Preventing transmission of human immunodeficiency virus infection.
West J Med. 1988 Feb;
148(2):198.
Blumenfeld W, Basgoz N, Owen WF Jr, Schmidt DM.
Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection.
Ann Intern Med. 1988 Sep 15;
109(6):505-7.
Owen WF Jr.
Medical evaluation of the gay male patient.
In: Stults BM, Dere WH, eds.
Practical Care of the Ambulatory Patient.
Philadelphia: W.B. Saunders, 1989: 351-81.
Owen WF Jr.
The changing nature of medicine in the era of HIV.
In: Abrams D, Gottlieb M, Grieco M, eds.
AIDS/HIV Experimental Treatment Directory. 1989 Aug;
3(2):42-5.
New York: American Foundation for AIDS Research.
Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Gordon SM, Owen WF Jr, Matthews Tr, Buhles WC, et al.
Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection.
J Infect Dis. 1991 Apr;
163(4):716-719.
Stricker RB, Sanders KA, Owen WF, Kiprov DD, Miller RG.
Mononeuritis multiplex associated with cryoglobulinemia in HIV infection.
Neurology. 1992 Nov;
42(11):2103-2105.
Jacobson MA, Owen W, Campbell J, Brosgart C, Abrams DI.
Tolerability of combined ganciclovir and didanosine for the treatment of cytomegalovirus disease associated with AIDS.
Clin Infect Dis. 1993 Feb;
16 Suppl 1():S69-73.
Lalezari JP, Drew WL, Glutzer E, Miner D, Safrin S, Owen WF Jr, Davidson JM, Fisher PE, Jaffe HS.
Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
J Infect Dis. 1994 Sep;
170(3):570-572.
Owen WF Jr.
Gay and bisexual men and medical care.
Chapter 41 in: Cabaj RP, Stein TS, eds.
Textbook of Homosexuality and Mental Health. 1996:673-86.
Washington, D.C.: American Psychiatric Press, Inc.
Berger D, Bucher G, Cimoch P, Nemechek P, Owen W, Steinhart C, Sullivan-Bolyai JZ.
Measurement of body weight and body cell mass in patients receiving highly active antiretroviral therapy (HAART).
Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy
Toronto, Ontario, Canada, September 28-October 1, 1997, Abstract I-26
Owen WF Jr.
Antiretroviral therapies
In Tinkle JD, guest ed.
Clinics in Podiatric Medicine and Surgery. 1998:227-39.
Philadelphia: W.B. Saunders
Owen WF Jr, Stein C
Efficacy and Durability of Delavirdine in Pharmacokinetic Enhancement of Protease Inhibitors for AIDS Patients with Extensive Antiretroviral Therapy (ART) Experience.
Abstracts of the XIII International AIDS Conference,
Durban, South Africa, July 9-14, 2000, Abstract WePeB4162
Schutz MR, Owen WF
Multi-center analysis of delavirdine as a pharmacokinetic enhancer in HIV infected adults with extensive prior HIV treatment.
Programs and Abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America,
New Orleans, Louisiana, September 7-10, 2000, Abstract 350
Owen WF, Stein C.
Delavirdine combined with protease inhibitors: durability and efficacy for salvage therapy in AIDS.
Program and Abstracts of the 39th Annual Meeting of the Infectious Diseases Society of America
San Francisco, California, October 25-28, 2001, Abstract 679
Owen Jr, WF, Chamberlain L, Warren DR, Ebrahimi R, Flaherty JF, Dong BJ.
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/r) in HIV-infected adults.
Program and Abstracts of the 3rd International AIDS Society Conference on Pathogenesis and Treatment,
Rio de Janeiro, Brazil, July 24-27, 2005, Abstract WePe6.3C10
Owen Jr, WF, Chamberlain L, Warren DR, Ebrahimi R, Dong BJ, Flaherty JF.
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/RTV) in HIV-infected adults.
Program and Abstracts of the 10th European AIDS Conference / EACS,
Dublin, Ireland, November 17-20, 2005, Abstract PE 7.3/6
Owen W, Chamberlain L, Warren D, Ebrahimi R, Dong B, Flaherty J.
Safety and efficacy of antiretroviral treatment (ART) regimens containing tenofovir DF (TDF) and atazanavir/ritonavir (ATV/r) in HIV-infected adults.
Program and Abstracts of the 15th Annual Canadian Conference on HIV/AIDS Research
Quebec City, Canada, May 25-28, 2006, Abstract 232P
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group
CD4+ Count-Guided Interruption of Antiretroviral Treatment.
N Engl J Med. 2006 Nov 30;
355(22):2283-96.
The International HIV Controllers Study
The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation
Science Express 2010 Nov 4;
http://www.sciencemag.org/content/330/6010/1551.abstract
Dong BJ, Ward DJ, Chamberlain LA, Reddy YS, Ebrahimi R, Flaherty JF, Owen WF.
Safety and Effectiveness of Tenofovir/Emtricitabine or Lamivudine Plus Ritonavir Boosted Atazanavir in Treatment Experienced HIV Infected Adults at Two Urban Private Medical Practices.
J Antivir Antiretrovir 2012 Jan 7; 4(1): 001-005
http://www.omicsonline.org/1948-5964/JAA-04-001.php

financial disclosure

grants/research support none
consultant/honoraria Bristol-Myers Squibb
Gilead Sciences
ViiV Healthcare
speakers' bureau Auxilium
Bristol-Myers Squibb
Gilead Sciences
Merck
Salix Pharmaceuticals
ViiV Healthcare
stock shareholder
(directly purchased)
Johnson & Johnson
Merck

[Home][Profile][Hours][Directions][Map][Hospitals][Groups][Insurance][Payment][Contact][resume][Carl's cv][Calendar][Services][What's New]

Last modified: May 24, 2015